DK1326628T3 - Kemokinmutanter til behandling af dissemineret sklerose - Google Patents
Kemokinmutanter til behandling af dissemineret skleroseInfo
- Publication number
- DK1326628T3 DK1326628T3 DK01986265T DK01986265T DK1326628T3 DK 1326628 T3 DK1326628 T3 DK 1326628T3 DK 01986265 T DK01986265 T DK 01986265T DK 01986265 T DK01986265 T DK 01986265T DK 1326628 T3 DK1326628 T3 DK 1326628T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- disseminated sclerosis
- chemokine mutants
- chemokine
- mutants
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00121665 | 2000-10-04 | ||
PCT/EP2001/011428 WO2002028419A2 (en) | 2000-10-04 | 2001-10-03 | Chemokine mutants in the treatment of multiple sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1326628T3 true DK1326628T3 (da) | 2004-08-09 |
Family
ID=8170011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01986265T DK1326628T3 (da) | 2000-10-04 | 2001-10-03 | Kemokinmutanter til behandling af dissemineret sklerose |
Country Status (31)
Country | Link |
---|---|
US (1) | US7402303B2 (sl) |
EP (1) | EP1326628B1 (sl) |
JP (1) | JP3908165B2 (sl) |
KR (1) | KR100837898B1 (sl) |
CN (1) | CN1285381C (sl) |
AR (1) | AR030854A1 (sl) |
AT (1) | ATE265222T1 (sl) |
AU (2) | AU1591902A (sl) |
BG (1) | BG66137B1 (sl) |
BR (1) | BR0114407A (sl) |
CA (1) | CA2423616C (sl) |
CZ (1) | CZ303409B6 (sl) |
DE (1) | DE60103078T2 (sl) |
DK (1) | DK1326628T3 (sl) |
EA (1) | EA006137B1 (sl) |
EE (1) | EE05174B1 (sl) |
ES (1) | ES2217199T3 (sl) |
HK (1) | HK1062811A1 (sl) |
HR (1) | HRP20030215B1 (sl) |
HU (1) | HUP0302194A3 (sl) |
IL (2) | IL155178A0 (sl) |
MX (1) | MXPA03003008A (sl) |
NO (1) | NO330278B1 (sl) |
PL (1) | PL204231B1 (sl) |
PT (1) | PT1326628E (sl) |
RS (1) | RS50738B (sl) |
SI (1) | SI1326628T1 (sl) |
SK (1) | SK287523B6 (sl) |
UA (1) | UA77950C2 (sl) |
WO (1) | WO2002028419A2 (sl) |
ZA (1) | ZA200302315B (sl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE421974T1 (de) | 2001-12-17 | 2009-02-15 | Serono Lab | Chemokine mutanten, die als chemokine antagonisten wirken |
JP2005529099A (ja) | 2002-04-04 | 2005-09-29 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | 改善された経口生物学的利用能を有するケモカイン変異体 |
EP1575608B1 (en) * | 2002-12-23 | 2008-05-07 | Laboratoires Serono SA | Use of cc-chemokine ccl5/rantes mutants against liver diseases |
CA2534828A1 (en) * | 2003-10-22 | 2005-05-06 | Applied Research Systems Ars Holding N.V. | Novel cxcl8 antagonists |
AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
DE60304435T2 (de) * | 2004-01-19 | 2006-08-24 | Ares Trading S.A. | Verfahren zur Reinigung von in Bakterien exprimierten Proteinen |
GB0412400D0 (en) * | 2004-06-03 | 2004-07-07 | Univ Newcastle | Treatment of inflammatory conditions |
EP1760110B1 (en) * | 2005-09-03 | 2011-11-02 | Samsung SDI Co., Ltd. | Polybenzoxazine-based compound, electrolyte membrane including the same, and fuel cell employing the electrolyte membrane |
GB0614755D0 (en) | 2006-07-25 | 2006-09-06 | Univ Geneve | Cytokine derivatives |
AU2008317495B2 (en) | 2007-08-02 | 2013-08-01 | Novimmune S.A. | Anti-RANTES antibodies and methods of use thereof |
CN102781952B (zh) * | 2010-02-08 | 2015-09-02 | 宾夕法尼亚大学托管会 | 编码rantes的核酸分子、包含其的组合物以及其使用方法 |
WO2019229615A1 (en) | 2018-05-28 | 2019-12-05 | Université De Genève | Methods of inhibiting cerebral inflammation |
WO2022093857A1 (en) * | 2020-10-26 | 2022-05-05 | City Of Hope | Oncolytic virus compositions and methods for the treatment of cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739103A (en) | 1993-11-12 | 1998-04-14 | Dana-Farber Cancer Institute | Chemokine N-terminal deletion mutations |
WO1998006751A1 (en) | 1996-08-16 | 1998-02-19 | Research Corporation Technologies, Inc. | Mcp-3, rantes and mip-1alpha receptor antagonists |
EP0906954A1 (en) * | 1997-09-29 | 1999-04-07 | Applied Research Systems ARS Holding N.V. | Amino-terminal truncated c-c chemokines as chemokine antagonist |
DK1040191T3 (da) * | 1997-12-23 | 2005-12-19 | San Raffaele Centro Fond | RANTES-mutanter og terapeutiske anvendelser heraf |
JP2002535376A (ja) * | 1999-01-29 | 2002-10-22 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | Ccr1アンタゴニストを用いた脱髄性炎症性疾患の治療方法 |
-
2001
- 2001-03-10 UA UA2003044038A patent/UA77950C2/uk unknown
- 2001-10-03 JP JP2002532243A patent/JP3908165B2/ja not_active Expired - Fee Related
- 2001-10-03 HU HU0302194A patent/HUP0302194A3/hu unknown
- 2001-10-03 CZ CZ20030947A patent/CZ303409B6/cs not_active IP Right Cessation
- 2001-10-03 DE DE60103078T patent/DE60103078T2/de not_active Expired - Lifetime
- 2001-10-03 AU AU1591902A patent/AU1591902A/xx active Pending
- 2001-10-03 SI SI200130130T patent/SI1326628T1/sl unknown
- 2001-10-03 CA CA2423616A patent/CA2423616C/en not_active Expired - Fee Related
- 2001-10-03 PT PT01986265T patent/PT1326628E/pt unknown
- 2001-10-03 DK DK01986265T patent/DK1326628T3/da active
- 2001-10-03 EP EP01986265A patent/EP1326628B1/en not_active Expired - Lifetime
- 2001-10-03 PL PL362350A patent/PL204231B1/pl not_active IP Right Cessation
- 2001-10-03 AU AU2002215919A patent/AU2002215919B2/en not_active Ceased
- 2001-10-03 WO PCT/EP2001/011428 patent/WO2002028419A2/en active IP Right Grant
- 2001-10-03 IL IL15517801A patent/IL155178A0/xx unknown
- 2001-10-03 ES ES01986265T patent/ES2217199T3/es not_active Expired - Lifetime
- 2001-10-03 AT AT01986265T patent/ATE265222T1/de active
- 2001-10-03 ZA ZA200302315A patent/ZA200302315B/en unknown
- 2001-10-03 EE EEP200300139A patent/EE05174B1/xx not_active IP Right Cessation
- 2001-10-03 SK SK406-2003A patent/SK287523B6/sk not_active IP Right Cessation
- 2001-10-03 RS YUP-257/03A patent/RS50738B/sr unknown
- 2001-10-03 MX MXPA03003008A patent/MXPA03003008A/es active IP Right Grant
- 2001-10-03 CN CNB018199178A patent/CN1285381C/zh not_active Expired - Fee Related
- 2001-10-03 KR KR1020037004599A patent/KR100837898B1/ko not_active IP Right Cessation
- 2001-10-03 BR BR0114407-3A patent/BR0114407A/pt not_active IP Right Cessation
- 2001-10-03 EA EA200300439A patent/EA006137B1/ru not_active IP Right Cessation
- 2001-10-03 US US10/398,457 patent/US7402303B2/en not_active Expired - Fee Related
- 2001-10-04 AR ARP010104684A patent/AR030854A1/es unknown
-
2003
- 2003-03-20 HR HR20030215A patent/HRP20030215B1/xx not_active IP Right Cessation
- 2003-03-28 BG BG107685A patent/BG66137B1/bg unknown
- 2003-04-01 IL IL155178A patent/IL155178A/en not_active IP Right Cessation
- 2003-04-03 NO NO20031525A patent/NO330278B1/no not_active IP Right Cessation
-
2004
- 2004-08-02 HK HK04105657A patent/HK1062811A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
DK0967214T3 (da) | Intranasale formuleringer til behandling af seksuelle forstyrrelser | |
DK1371647T3 (da) | Pyrazolopyrimidinon-cGMP PDE5-inhibitorer til behandling af sexualforstyrrelse | |
DK1047428T3 (da) | Anvendelse af morpholinol til behandlingen af seksualforstyrrelser | |
MA25996A1 (fr) | Inhibiteurs de phosphodiesterase 4. | |
FI20001993A0 (fi) | Puhelinneuvottelu | |
DK1392318T3 (da) | 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse | |
DK1309581T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK1326628T3 (da) | Kemokinmutanter til behandling af dissemineret sklerose | |
DK2189162T3 (da) | Fremgangsmåder til behandling af cellulære proliferative forstyrrelser | |
DK1345598T3 (da) | Anvendelsen af rosiglitazon til behandling af psykiatriske lidelser | |
DK1296970T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
DK1292586T3 (da) | Fremgangsmåde til fremstilling af pyrazolopyrimidinoner | |
DE60103664D1 (de) | Schwarzschulterklemmung | |
EE200200693A (et) | Interferoon hulgiskleroosi raviks | |
DK1390364T3 (da) | Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression | |
DK1468686T3 (da) | S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser | |
DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
DK1286940T3 (da) | Fremgangsmåde til fluormethylering af alkoholer | |
DK1242089T3 (da) | Anvendelse af adatanserin til behandling af akutte neutodegenerative lidelser | |
IT251123Y1 (it) | Dispositivo per l'introduzione di supposte . | |
DK1200350T3 (da) | Fremgangsmåde til fremstilling af kvasi-krystallinske boehmitter | |
DK1196184T3 (da) | Sammensætninger til behandling af seksuel dysfunktion |